Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 2 of 15

→ Is this Nvidia's secret weapon? (From Manward Press) (Ad)
Slide 2
Back to 1
Continue to 3
 
Back to 1
Continue to 3
 

United Therapeutics (NASDAQ:UTHR)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
9 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$308.78 (18.8% Upside)

About United Therapeutics

United Therapeutics logoUnited Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/3/2024The Goldman Sachs GroupBoost Price TargetNeutral ➝ Neutral$218.00 ➝ $240.00
5/2/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$375.00 ➝ $400.00
5/2/2024HC WainwrightReiterated RatingBuy ➝ Buy$300.00
3/7/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$309.00 ➝ $325.00
2/22/2024WedbushReiterated RatingOutperform ➝ Outperform$308.00
2/22/2024HC WainwrightReiterated RatingBuy ➝ Buy$300.00
2/12/2024The Goldman Sachs GroupUpgradeSell ➝ Neutral$213.00 ➝ $215.00
2/5/2024Leerink PartnrsReiterated RatingOutperform
2/5/2024SVB LeerinkInitiated CoverageOutperform$330.00
12/8/2023Wells Fargo & CompanyInitiated CoverageOverweight$309.00
Slide 2
Back to 1
Continue to 3
 

Is this Nvidia's secret weapon? (Ad)

You've likely heard about Nvidia's incredible success in AI. But there's an untold story that could be even bigger.

Click here to discover the AI chip company

More From MarketBeat
Is this Nvidia's secret weapon?
from Manward Press
7 Best $5 Dollar Stocks to Buy
from MarketBeat
Could Your Accounts Be Frozen?
from Allegiance Gold
15 REITs That Wall Street Analysts Love in Today's Market
from MarketBeat
Never use this word on your phone (FBI could be watching)
from Paradigm Press
12 Cannabis Stocks to Buy Now
from MarketBeat